JP2019011314A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019011314A5 JP2019011314A5 JP2018122078A JP2018122078A JP2019011314A5 JP 2019011314 A5 JP2019011314 A5 JP 2019011314A5 JP 2018122078 A JP2018122078 A JP 2018122078A JP 2018122078 A JP2018122078 A JP 2018122078A JP 2019011314 A5 JP2019011314 A5 JP 2019011314A5
- Authority
- JP
- Japan
- Prior art keywords
- food
- food composition
- regulatory
- adjuvant
- allergen immunotherapy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000013305 food Nutrition 0.000 claims 22
- 239000013566 allergen Substances 0.000 claims 14
- 208000026935 allergic disease Diseases 0.000 claims 11
- 238000009169 immunotherapy Methods 0.000 claims 11
- 210000003289 regulatory T cell Anatomy 0.000 claims 10
- 239000002671 adjuvant Substances 0.000 claims 8
- 208000027866 inflammatory disease Diseases 0.000 claims 8
- 239000000411 inducer Substances 0.000 claims 7
- 208000004262 Food Hypersensitivity Diseases 0.000 claims 6
- 206010016946 Food allergy Diseases 0.000 claims 6
- 239000004480 active ingredient Substances 0.000 claims 6
- 235000020932 food allergy Nutrition 0.000 claims 6
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims 4
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims 4
- 239000003795 chemical substances by application Substances 0.000 claims 4
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims 4
- 229960004999 lycopene Drugs 0.000 claims 4
- 235000012661 lycopene Nutrition 0.000 claims 4
- 239000001751 lycopene Substances 0.000 claims 4
- 230000002265 prevention Effects 0.000 claims 4
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 3
- 230000000069 prophylactic effect Effects 0.000 claims 3
- 229940124597 therapeutic agent Drugs 0.000 claims 3
- 230000001225 therapeutic effect Effects 0.000 claims 3
- 206010009887 colitis Diseases 0.000 claims 2
- 235000015872 dietary supplement Nutrition 0.000 claims 1
- 235000013402 health food Nutrition 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 230000003449 preventive effect Effects 0.000 claims 1
- 239000013589 supplement Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017127846 | 2017-06-29 | ||
| JP2017127846 | 2017-06-29 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019011314A JP2019011314A (ja) | 2019-01-24 |
| JP2019011314A5 true JP2019011314A5 (enrdf_load_stackoverflow) | 2019-09-26 |
| JP6892079B2 JP6892079B2 (ja) | 2021-06-18 |
Family
ID=65227877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018122078A Active JP6892079B2 (ja) | 2017-06-29 | 2018-06-27 | 制御性ｔ細胞誘導剤、アジュバント及び食品組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6892079B2 (enrdf_load_stackoverflow) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2021143142A (ja) * | 2020-03-11 | 2021-09-24 | 花王株式会社 | 制御性ｔ細胞誘導剤 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4328514B2 (ja) * | 2002-11-11 | 2009-09-09 | カゴメ株式会社 | 抗アレルギー剤 |
| SG11201607674SA (en) * | 2014-03-14 | 2016-11-29 | Meiji Co Ltd | Retinoic-acid-producing agent |
| WO2017005647A1 (en) * | 2015-07-03 | 2017-01-12 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for obtaining regulatory t cells and uses thereof |
| WO2017055235A1 (en) * | 2015-09-30 | 2017-04-06 | Boehringer Ingelheim Vetmedica Gmbh | Improved modular antigen transportation molecules and uses therof in animals |
| JP2017081891A (ja) * | 2015-10-27 | 2017-05-18 | 株式会社ホソダＳｈｃ | 制御性ｔ細胞活性組成物 |
-
2018
- 2018-06-27 JP JP2018122078A patent/JP6892079B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Trukhachev et al. | Development of technology for food for people with hypersthenic body type | |
| Larenas-Linnemann et al. | Enhancing innate immunity against virus in times of COVID-19: Trying to untangle facts from fictions | |
| MX395637B (es) | Composiciones de alergenos alimentarios. | |
| JP2019011314A5 (enrdf_load_stackoverflow) | ||
| CN105311195A (zh) | 一种治皮肤瘙痒的配方 | |
| Shadur et al. | Desensitisation to liposomal amphotericin B | |
| Tavsanli et al. | Fear of falling in elderly people living in a nursing home—Perspective from Manisa | |
| WO2018078599A3 (en) | Composition for the preventive or curative treatment of liver disorders | |
| Subgroup et al. | Diagnosis and therapy guideline of preterm birth (2014) | |
| Patel et al. | Immunomodulatory effects of probiotics in the treatment of human immunodeficiency virus (HIV) infection | |
| WO2016159583A3 (ko) | 지구자 추출물을 유효성분으로 함유하는 선천면역 증진 및 항바이러스용 조성물 | |
| Hausman | Post-traumatic Stress Disorder (PTSD) | |
| Ubaldo | Laugh | |
| Sevbitov et al. | CHANGE OF ANTITRYPTIC ACTIVITY OF MIXED SALIVA IN ORTHOPEDIC PATIENTS WITH SYNDROME OF INTOLERANCE TO ACRYLIC PLASTICS DURING PROSTHETICS WITH REMOVABLE PLATE PROSTHESES | |
| ES2627553B1 (es) | Identificación de solanácea pruritógena mediante aplicación cutánea de sus alcaloides | |
| JP2016028097A5 (enrdf_load_stackoverflow) | ||
| Khripun et al. | Non-occlusive form of acute mesenteric circulatory disorders: diagnosis and treatment | |
| Kemp et al. | The allergy epidemic: what is the Australian response? | |
| Kelesidis et al. | Therapeutic Advances in Gastroenterology | |
| Fakhraddeen Muhammad MBBS et al. | PREVALENCE AND DETERMINANTS OF METABOLIC SYNDROME AMONG HIV INFECTED PATIENTS RECEIVING HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) IN KANO, NORTHWESTERN NIGERIA | |
| Herath et al. | Awareness of first aid for snake bites among villagers in a rural area | |
| Kaku | The 41st Scientific Meeting: perspectives of internal medicine; lessons from the disaster of the Great East Japan earthquake; 3. Medical disease learned from the Great East Japan earthquake--feature, treatment and prevention-; 5) Total management for infectious diseases | |
| Delarue et al. | NEONATOLOGY CRITICAL CARE 134 AND SIMULATION TECHNIQUES | |
| Rather et al. | In Vitro and In Vivo Inhibition of Atopic Dermatitis (AD) by a Novel Probiotic Isolate Lactobacillus sakei Probio-65 | |
| Yamauchi | The 41st Scientific Meeting: perspectives of internal medicine; lessons from the disaster of the Great East Japan earthquake; 3. Medical disease learned from the Great East Japan earthquake--feature, treatment and prevention--; 2) Respiratory diseases |